Follow the people · Insider

FM

Fady Ibraham Malik

Insider · EVP Research & Development · CYTK

Fady Ibraham Malik files insider transactions with the SEC as an evp research & development of Cytokinetics (CYTK). We hold 12 disclosed purchases and sales filed since 5 September 2012, 5 of them in the last 90 days.

  • Files forCYTK
  • Disclosed buys and sells12 in all, 5 in the last 90 days
  • Last disclosure8 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 4 September 20128 September 2026EVP Research & Development · Cytokinetics (CYTK)388 Form 4 lines · source: SEC Form 4
  • Filed 10 March 202218 June 2026Director · Rocket Pharmaceuticals (RCKT)8 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.